Atai Life Sciences Receivables 2020-2024 | ATAI
Atai Life Sciences receivables from 2020 to 2024. Receivables can be defined as the total amount of collectibles for a company
| Atai Life Sciences Annual Receivables (Millions of US $) |
|
|---|---|
| 2023 | $ |
| 2022 | $ |
| 2021 | $ |
| 2020 | $ |
| 2019 | $ |
| Atai Life Sciences Quarterly Receivables (Millions of US $) |
|
|---|---|
| 2024-09-30 | |
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | $21 |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.252B | $0.000B |
| atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $21.703B | 0.00 |
| Quest Diagnostics (DGX) | United States | $17.349B | 17.58 |
| DaVita (DVA) | United States | $14.249B | 18.43 |
| Encompass Health (EHC) | United States | $9.629B | 22.70 |
| Chemed (CHE) | United States | $8.394B | 25.80 |
| Elanco Animal Health (ELAN) | United States | $6.076B | 14.46 |
| Option Care Health (OPCH) | United States | $5.267B | 24.96 |
| RadNet (RDNT) | United States | $4.972B | 110.11 |
| LifeStance Health (LFST) | United States | $3.092B | 0.00 |
| Amedisys (AMED) | United States | $3.023B | 21.51 |
| Addus HomeCare (ADUS) | United States | $2.290B | 26.87 |
| Astrana Health (ASTH) | United States | $2.076B | 28.39 |
| U.S Physical Therapy (USPH) | United States | $1.337B | 35.14 |
| Pennant (PNTG) | United States | $0.945B | 38.21 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.945B | 0.00 |
| Bioqual (BIOQ) | United States | $0.055B | 0.00 |
| Daxor (DXR) | United States | $0.038B | 0.00 |
| Ontrak (OTRK) | United States | $0.007B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.004B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.002B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |